ATE447586T1 - Fprl1-liganden und deren verwendung - Google Patents

Fprl1-liganden und deren verwendung

Info

Publication number
ATE447586T1
ATE447586T1 AT03810620T AT03810620T ATE447586T1 AT E447586 T1 ATE447586 T1 AT E447586T1 AT 03810620 T AT03810620 T AT 03810620T AT 03810620 T AT03810620 T AT 03810620T AT E447586 T1 ATE447586 T1 AT E447586T1
Authority
AT
Austria
Prior art keywords
fprl1
seq
amino acid
acid sequence
ligands
Prior art date
Application number
AT03810620T
Other languages
English (en)
Inventor
Shuji Hinuma
Makoto Kobayashi
Yugo Habata
Masataka Harada
Shoichi Okubo
Hiromi Yoshida
Kazunori Nishi
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE447586T1 publication Critical patent/ATE447586T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT03810620T 2002-11-07 2003-11-06 Fprl1-liganden und deren verwendung ATE447586T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2002324189 2002-11-07
JP2002367119 2002-12-18
JP2003059073 2003-03-05
JP2003191359 2003-07-03
PCT/JP2003/014138 WO2004041850A1 (ja) 2002-11-07 2003-11-06 新規なｆｐｒｌ１リガンドおよびその用途

Publications (1)

Publication Number Publication Date
ATE447586T1 true ATE447586T1 (de) 2009-11-15

Family

ID=32314929

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03810620T ATE447586T1 (de) 2002-11-07 2003-11-06 Fprl1-liganden und deren verwendung

Country Status (6)

Country Link
US (1) US7943137B2 (de)
EP (1) EP1559721B1 (de)
AT (1) ATE447586T1 (de)
AU (1) AU2003277575A1 (de)
DE (1) DE60329931D1 (de)
WO (1) WO2004041850A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002332929A1 (en) 2001-09-07 2003-03-24 Bristol-Myers Squibb Company Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy39
JP5502480B2 (ja) * 2006-09-18 2014-05-28 コンピュゲン エルティーディー． 生物活性ペプチド及びその使用方法
CN106518742B (zh) 2011-10-26 2020-01-21 阿勒根公司 作为甲酰肽受体样-1(fprl-1)受体调节剂的n-脲取代的氨基酸的酰胺衍生物
BR122017004254B1 (pt) * 2013-03-06 2021-04-13 Allergan, Inc. Uso de agonistas de receptor de formil peptídeo 2 para tratar doenças inflamatórias oculares

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2030000A (en) * 1998-11-25 2000-06-13 Cadus Pharmaceutical Corporation Methods and compositions for identifying receptor effectors
CA2399032A1 (en) 2000-02-04 2001-08-09 The Government Of The United States Of America Ligands for fpr class receptors that induce a host immune response to a pathogen or inhibit hiv infection
JP5500749B2 (ja) * 2000-03-07 2014-05-21 日本たばこ産業株式会社 好中球刺激活性を有するポリペプチド
US7172876B2 (en) 2002-06-14 2007-02-06 Takeda Pharmaceutical Company Limited Method of screening therapeutic agents for nerve degeneration associated diseases
WO2004008141A1 (ja) 2002-07-15 2004-01-22 Takeda Chemical Industries, Ltd. 新規スクリーニング方法

Also Published As

Publication number Publication date
AU2003277575A1 (en) 2004-06-07
US7943137B2 (en) 2011-05-17
US20070065819A1 (en) 2007-03-22
EP1559721A4 (de) 2006-03-29
WO2004041850A1 (ja) 2004-05-21
DE60329931D1 (de) 2009-12-17
EP1559721B1 (de) 2009-11-04
EP1559721A1 (de) 2005-08-03

Similar Documents

Publication Publication Date Title
DE60332320D1 (de) Neues screening-verfahren
EA200401169A1 (ru) Аминометилзамещенные тетрациклиновые соединения
DK1706424T3 (da) FC-region varianter
DE69932738D1 (de) 3-azabicyclo(3.1.0)hexanderivate als opiat rezeptoren liganden
ATE392430T1 (de) Verfahren zur herstellung von dipeptiden
DE60325493D1 (de) Substituierte 1,4-dipiperidin-4-yl-piperazinderivate und deren verwendung als neurokininantagonisten
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
EP1700120A4 (de) Marker für neuromyelitis optica
DE60335216D1 (de) Adiponektin-rezeptor und dafür kodierendes gen
PT1454992E (pt) Ensaio de quinase do linfoma anaplastico, reagentes e composicoes
DE602005011593D1 (de) Substituierte diazaspiroä5.5üundecanderivate und deren verwendung als neurokininantagonisten
DK1645626T3 (da) Cellelinie
IL165031A0 (en) Quality assays for antigen presenting cells
ATE447586T1 (de) Fprl1-liganden und deren verwendung
AP2006003544A0 (en) Amino acids with affinity for the alpha2delta-protein.
EA200500878A1 (ru) Кальцилитические соединения
DE60319989D1 (de) Diazabicylononan - und decanderivate und ihre verwendung als opioid-rezeptorligande
DE60226244D1 (de) Il-4 rezeptor sequenzvarianten, die mit typ i diabetes assoziiert sind
FR2874483B1 (fr) Procede de gradation automatique d'articles, notamment de vetements
ATE511644T1 (de) Neues screening-verfahren
WO2005100386A3 (en) Canine cold-and menthol-sensitive receptor 1
ATE494550T1 (de) Neues screening-verfahren
WO2003082320A1 (fr) Nouveau procede de criblage
GEP20084464B (en) Mutated neublastin
DE602004023493D1 (de) Neues screening-verfahren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties